Alzheimer’s Association Endorses New Drug
HARRISONBURG, Va. (WHSV) - Monday the FDA approved the drug Aduhelm to combat Alzheimer’s. It is the first new Alzheimer’s medication approved since 2003.
Unlike previous medications, experts say this one actually slows the progression of the disease instead of just treating the symptoms.
It works by targeting a protein in the brain called beta-amyloid which is the primary component of the amyloid plaques that is found in the brains of people with Alzheimer’s.
“This drug helps to remove beta-amyloid from the brain and thus we have seen that there is a delay in the decline and progression of the disease in those who are diagnosed in those early stages,” said Katie McDonough, the director of program and services for the eastern Virginia branch of the Alzheimer’s association.
The association says the approval of this drug is a monumental step in Alzheimer’s research and provides more options for those diagnosed with it.
Copyright 2021 WHSV. All rights reserved.